BlackRock Fund Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History

BlackRock Fund Advisors’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$15.8M	Buy	1,714,727 +162,477	+10%	+$1.84M	﹤0.01%	2313
2016 Q3	$18.3M	Buy	1,552,250 +73,495	+5%	+$1.12M	﹤0.01%	2121
2016 Q2	$19.1M	Sell	1,478,755 -20,113	-1%	-$293K	﹤0.01%	2047
2016 Q1	$24M	Buy	1,498,868 +83,040	+6%	+$1.58M	0.01%	1880
2015 Q4	$40.5M	Sell	1,415,828 -169,482	-11%	-$4.7M	0.01%	1621
2015 Q3	$45.1M	Buy	1,585,310 +99,971	+7%	+$3.68M	0.01%	1486
2015 Q2	$53.4M	Buy	1,485,339 +50,949	+4%	+$1.59M	0.01%	1479
2015 Q1	$41.7M	Buy	1,434,390 +44,216	+3%	+$1.17M	0.01%	1628
2014 Q4	$29.3M	Buy	1,390,174 +69,854	+5%	+$1.38M	0.01%	1834
2014 Q3	$25.6M	Buy	1,320,320 +19,668	+2%	+$309K	0.01%	1796
2014 Q2	$20.3M	Buy	1,300,652 +91,572	+8%	+$1.48M	0.01%	2013
2014 Q1	$25M	Buy	1,209,080 +52,532	+5%	+$1.04M	0.01%	1872
2013 Q4	$14.9M	Buy	1,156,548 +721,722	+166%	+$10M	﹤0.01%	2146
2013 Q3	$5.07M	Buy	434,826 +56,241	+15%	+$462K	﹤0.01%	2805
2013 Q2	$1.75M	Buy	+378,585	New	+$1.39M	﹤0.01%	3118

Other funds holding INSY

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FHAM

Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BlackRock Fund Advisors's INSY Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Insys Therapeutics, Inc. (INSY) stake by 10% in Q4 2016, buying an estimated $1.84M and bringing the position to 1,714,727 shares worth $15.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2313.

BlackRock Fund Advisors first reported a position in INSY in Q2 2013 and has held it in 15 quarters since. The position peaked at $53.4M in Q2 2015. 138 funds tracked by Wall St. Rank hold INSY as of Q4 2016.

BlackRock Fund Advisors held 1,714,727 shares of Insys Therapeutics, Inc. worth $15.8M as of Q4 2016.
BlackRock Fund Advisors bought 162,477 Insys Therapeutics, Inc. shares in Q4 2016, an estimated $1.84M.
Insys Therapeutics, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2313 holding.
BlackRock Fund Advisors first reported a position in Insys Therapeutics, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Insys Therapeutics, Inc. position peaked at $53.4M in Q2 2015.
138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.